Anna Lundahl
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
-
- Wound Healing and Treatments
Papers in
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 11
- Drug-Induced Hepatotoxicity and Protection 3
- Oncology 10
- Drug Transport and Resistance Mechanisms 10
- Co-authors
- Hans Lennernäs (9 shared papers)Mikael Hedeland (5 shared papers)Ulf Bondesson (5 shared papers)Lars Knutson (4 shared papers)Helena Thörn (1 shared paper)Paul A. Dickinson (1 shared paper)J. A. Schrickx (1 shared paper)Kajsa P. Kanebratt (2 shared papers)
- Journals
- Drug Metabolism and Disposition (5 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)European Journal of Pharmaceutical Sciences (2 papers)Scientific Reports (1 paper)Xenobiotica (1 paper)
- Partner nations
- SwedenFinlandUnited States
In The Last Decade
Anna Lundahl
18 papers receiving 312 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 106
- Rehabilitation 30
- Oncology 101
- Pharmaceutical Science 21
- Pharmacology 39
Countries citing papers authored by Anna Lundahl
This map shows the geographic impact of Anna Lundahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lundahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lundahl more than expected).
Fields of papers citing papers by Anna Lundahl
This network shows the impact of papers produced by Anna Lundahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lundahl. The network helps show where Anna Lundahl may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Lundahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 86 | |
| 2 | 2011 | 51 | |
| 3 | 2009 | 28 | |
| 4 | 2008 | 26 | |
| 5 | 2018 | 26 | |
| 6 | 2018 | 16 | |
| 7 | 2009 | 15 | |
| 8 | 2011 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 9 | |
| 11 | 2015 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2010 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2013 | 4 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 1 | |
| 18 | In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites | 2010 | 1 |
About Anna Lundahl
Anna Lundahl is a scholar working on Pharmacology, Oncology, Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 18 papers that have together received 316 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (10 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Metabolism and Genetic Disorders (2 papers), Computational Drug Discovery Methods (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Wound Healing and Treatments (2 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Pharmacology (106 citations), Rehabilitation (30 citations), Oncology (101 citations), Pharmaceutical Science (21 citations) and Pharmacology (39 citations). Anna Lundahl has collaborated with scholars based in Sweden, Finland and United States. Frequent co-authors include Hans Lennernäs, Mikael Hedeland, Ulf Bondesson, Lars Knutson, Helena Thörn, Paul A. Dickinson, J. A. Schrickx, Kajsa P. Kanebratt, Anthony C. Bruce and Chenchu Zhang. Their work appears in journals such as Drug Metabolism and Disposition, CPT Pharmacometrics & Systems Pharmacology, European Journal of Pharmaceutical Sciences, Scientific Reports and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.